Thursday, April 24, 2014
FAIRFIELD-SUISUN, CALIFORNIA
99 CENTS

Gene therapy scores big wins against blood cancers

Gene Therapy Cancer

This Nov. 18, 2013 photo provided by the The Children's Hospital of Philadelphia shows Emily Whitehead, 8, 20 months after T Cell Therapy treatment in Philadelphia. In one of the biggest advances against leukemia and other blood cancers in many years, doctors are reporting unprecedented success by using gene therapy to transform patients' blood cells into soldiers that seek and destroy their cancer. (AP Photo/The Children's Hospital of Philadelphia, Ed Cunicelli)

By
From page A1 | December 08, 2013 | 1 Comment

In one of the biggest advances against leukemia and other blood cancers in many years, doctors are reporting unprecedented success by using gene therapy to transform patients’ blood cells into soldiers that seek and destroy cancer.

A few patients with one type of leukemia were given this one-time, experimental therapy several years ago and some remain cancer-free today. Now, at least six research groups have treated more than 120 patients with many types of blood and bone marrow cancers, with stunning results.

“It’s really exciting,” said Dr. Janis Abkowitz, blood diseases chief at the University of Washington in Seattle and president of the American Society of Hematology. “You can take a cell that belongs to a patient and engineer it to be an attack cell.”

In one study, all five adults and 19 of 22 children with acute lymphocytic leukemia, or ALL, had a complete remission, meaning no cancer could be found after treatment, although a few have relapsed since then.

These were gravely ill patients out of options. Some had tried multiple bone marrow transplants and up to 10 types of chemotherapy or other treatments.

Cancer was so advanced in 8-year-old Emily Whitehead of Philipsburg, Pa., that doctors said her major organs would fail within days. She was the first child given the gene therapy and shows no sign of cancer today, nearly two years later.

Results on other patients with myeloma, lymphoma and chronic lymphocytic leukemia, or CLL, will be reported at the hematology group’s conference that starts Saturday in New Orleans.

Doctors say this has the potential to become the first gene therapy approved in the United States and the first for cancer worldwide. Only one gene therapy is approved in Europe, for a rare metabolic disease.

The treatment involves filtering patients’ blood to remove millions of white blood cells called T-cells, altering them in the lab to contain a gene that targets cancer, and returning them to the patient in infusions over three days.

“What we are giving essentially is a living drug” – permanently altered cells that multiply in the body into an army to fight the cancer, said Dr. David Porter, a University of Pennsylvania scientist who led one study.

Several drug and biotech companies are developing these therapies. Penn has patented its method and licensed it to Switzerland-based Novartis AG. The company is building a research center on the Penn campus in Philadelphia and plans a clinical trial next year that could lead to federal approval of the treatment as soon as 2016.

Talking with the researchers, “there is a sense of making history … a sense of doing something very unique,” said Herv√© Hoppenot, president of Novartis Oncology, the division leading the work.

Lee Greenberger, chief scientific officer of the Leukemia and Lymphoma Society, agreed.

“From our vantage point, this looks like a major advance,” he said. “We are seeing powerful responses … and time will tell how enduring these remissions turn out to be.”

The group has given $15 million to various researchers testing this approach. Nearly 49,000 new cases of leukemia, 70,000 cases of non-Hodgkin lymphoma and 22,000 cases of myeloma are expected to be diagnosed in the United States in 2013.

Many patients are successfully treated with chemotherapy or bone marrow or stem cell transplants, but transplants are risky and donors can’t always be found. So far, gene therapy has been tried on people who were in danger of dying because other treatments failed.

The gene therapy must be made individually for each patient, and lab costs now are about $25,000, without a profit margin. That’s still less than many drugs to treat these diseases and far less than a transplant.

The treatment can cause severe flu-like symptoms and other side effects, but these have been reversible and temporary, doctors say.

Penn doctors have treated the most cases so far – 59. Of the first 14 patients with CLL, four had complete remissions, four had partial ones and the rest did not respond. However, some partial responders continue to see their cancer shrink a year after treatment.

“That’s very unique to this kind of therapy” and gives hope the treatment may still purge the cancer, said Porter. Another 18 CLL patients were treated and half have responded so far.

Penn doctors also treated 27 ALL patients. All five adults and 19 of the 22 children had complete remissions, an “extraordinarily high” success rate, said Dr. Stephan Grupp at the Children’s Hospital of Philadelphia.

Six have since relapsed, though, and doctors are pondering a second gene therapy attempt.

At the National Cancer Institute, Dr. James Kochenderfer and others have treated 11 patients with lymphoma and four with CLL, starting roughly two years ago. Six had complete remissions, six had partial ones, one has stable disease and it’s too soon to tell for the rest.

Ten other patients were given gene therapy to try to kill leukemia or lymphoma remaining after bone marrow transplants. These patients got infusions of gene-treated blood cells from their transplant donors instead of using their own blood cells. One had a complete remission and three others had significant reduction of their disease.

“They’ve had every treatment known to man. To get any responses is really encouraging,” Kochenderfer said. The cancer institute is working with a Los Angeles biotech firm, Kite Pharma Inc., on its gene therapy approach.

Researchers at Memorial Sloan-Kettering Cancer Center will report on 13 patients with ALL; the University of Texas MD Anderson Cancer Center will report about two-dozen patients with ALL or lymphoma, and Baylor University will give results on 10 patients with lymphoma or myeloma.

Patients are encouraged that relatively few have relapsed.

“We’re still nervous every day because they can’t tell us what’s going to happen tomorrow,” said Tom Whitehead, 8-year-old Emily’s father.

Doug Olson, 67, a scientist for a medical device maker, shows no sign of cancer since gene therapy in September 2010 for CLL he had had since 1996.

“Within one month he was in complete remission. That was just completely unexpected,” said Porter, his doctor at Penn.

Olson ran his first half-marathon in January and no longer worries about how long his remission will last.

“I decided I’m cured. I’m not going to let that hang over my head anymore,” he said.

___

Online:

Emily Whitehead’s story: http://bit.ly/VxB0dL

The Associated Press

The Associated Press

LEAVE A COMMENT

Discussion | 1 comment

The Daily Republic does not necessarily condone the comments here, nor does it review every post. Read our full policy

.

Solano News

 
Congressman talks Travis, water

By Barry Eberling | From Page: A1, 4 Comments | Gallery

Travis lines up 2 days of aviation excellence

By Ian Thompson | From Page: A1, 1 Comment | Gallery

 
Appreciate how good we have it now

By Angela Borchert | From Page: A2

 
 
Dixon May Fair has deals on advance tickets

By Amy Maginnis-Honey | From Page: A3

 
Garamendi talks love, pro football and Peace Corps

By Ryan McCarthy | From Page: A3, 4 Comments | Gallery

 
Author to sign books at Vacaville Museum

By Amy Maginnis-Honey | From Page: A3

Kroc Center women schedule inaugural Taster Tea

By Amy Maginnis-Honey | From Page: A3

 
Docents to lead paddling tour in marsh

By Adrienne Harris | From Page: A4

Juneteenth committee extends vendors, exhibitors deadline

By Amy Maginnis-Honey | From Page: A4

 
Congressional Art Competition is back

By Susan Hiland | From Page: A4

 
Spilled tomato juice case set for trial

By Ryan McCarthy | From Page: A4, 5 Comments

Theme park welcomes seal pup

By Adrienne Harris | From Page: A4

 
 
Suisun City police log: April 22, 2014

By Susan Hiland | From Page: A12

 
Suisun City police log: April 21, 2014

By Susan Hiland | From Page: A12

Fairfield police log: April 21, 2014

By Susan Hiland | From Page: A12

 
Weather for Thursday, April 24, 2014

By Daily Republic staff | From Page: B12

Fairfield police log: April 22, 2014

By Susan Hiland | From Page: A12

 
.

US / World

Syrian activists accuse Assad of new gas attacks

By The Associated Press | From Page: A1

 
Murder charge for Vallejo man in head-on crash

By The Associated Press | From Page: A5, 1 Comment

California bill reignites affirmative action fight

By The Associated Press | From Page: A5, 3 Comments

 
Andy Lopez protest leads to school campus lockdown

By The Associated Press | From Page: A5, 3 Comments

Navy Cross bestowed on heroic Marine

By The Associated Press | From Page: A5, 1 Comment

 
Airport official: Teen had no clue he was in Maui

By The Associated Press | From Page: A5

US weighs clemency for inmates jailed for 10 years

By The Associated Press | From Page: A6, 1 Comment

 
Gun carry rights expanded in Ga. under new law

By The Associated Press | From Page: A6, 4 Comments

First lady announces one-stop job site for vets

By The Associated Press | From Page: A6, 2 Comments

 
Rail safety effort marred by squabbling

By The Associated Press | From Page: A6, 1 Comment

Small Wyoming town evacuated after gas explosion

By The Associated Press | From Page: A6

 
Bashtag: NYPD Twitter campaign backfires

By The Associated Press | From Page: A6, 1 Comment

Soldier convicted in WikiLeaks case gets new name

By The Associated Press | From Page: A6

 
Lawyer: US man held in Cuba seeks to go home soon

By The Associated Press | From Page: A10, 1 Comment

Captain who left doomed ferry had 40 years at sea

By The Associated Press | From Page: A10

 
Russian social media CEO quits, flees country

By The Associated Press | From Page: A10

Amid Russia warning, Ukraine is in a security bind

By The Associated Press | From Page: A10, 1 Comment

 
Palestinian rivals to try again for unity deal

By The Associated Press | From Page: A10

Camilla’s brother dies in US after head injury

By The Associated Press | From Page: A10

 
State senators get ethics training after scandals

By The Associated Press | From Page: A12, 7 Comments

.

Opinion

Question of the week: Will Flight 370 be found?

By Daily Republic | From Page: A11

 
Be the first and give specifics

By Letter to the Editor | From Page: A11, 2 Comments

What we can do about crime

By Kelvin Wade | From Page: A11, 14 Comments

 
Castro at odds with mentor on deportations

By Ruben Navarrette | From Page: A11

Some Earth Day boos and cheers

By Jay Ambrose | From Page: A11

 
.

Living

Today in History for April 24, 2014

By The Associated Press | From Page: A2

 
Community Calendar: April 24, 2014

By Susan Hiland | From Page: A2

When Joe’s mad at me, he also ignores my 7-year-old son

By Kathy Mitchell and Marcy Sugar | From Page: A9

 
Horoscopes for April 24, 2014

By Holiday Mathis | From Page: A9

.

Entertainment

TVGrid

By Daily Republic Syndicated Content | From Page: B5

 
Jodie Foster weds artist Alexandra Hedison

By The Associated Press | From Page: A7

Singer Chris Brown’s DC trial delayed for months

By The Associated Press | From Page: A7

 
Performing dogs go big after $1 million TV prize

By The Associated Press | From Page: A7

Amazon snares classic shows in deal with HBO

By The Associated Press | From Page: A7

 
.

Sports

Mustangs swim to sweep of Indians

By Marcus Lomtong | From Page: B1 | Gallery

 
Warriors, Clippers to meet in Oakland for Game 3

By The Associated Press | From Page: B1

Sharks confident with chance to sweep LA Kings

By The Associated Press | From Page: B1

 
Girls soccer update: Armijo, Vanden on way to playoffs

By Paul Farmer | From Page: B1 | Gallery

A’s reject 10-year Coliseum lease offer

By The Associated Press | From Page: B2

 
Prep softball: Vanden rolls to 14-0 win over Fairfield

By Daily Republic staff | From Page: B2

 
Prep badminton: Unbeaten Mustangs cruise past Crushers

By Daily Republic staff | From Page: B2

Prep boys golf: Vikings suffer SCAC loss to Panthers

By Daily Republic staff | From Page: B2

 
Sanchez’s slam in 11th helps Giants beat Rox 12-10

By The Associated Press | From Page: B2 | Gallery

Prep track: Armijo girls get win in MEL 4-way meet

By Daily Republic staff | From Page: B2

 
Perez helps Rangers sweep A’s with 3-0 win

By The Associated Press | From Page: B2 | Gallery

Party a century in the making for Wrigley Field

By The Associated Press | From Page: B2

 
Emmert supports more efficient, effective NCAA

By The Associated Press | From Page: B3

Phelps having fun in his return to swimming

By The Associated Press | From Page: B3 | Gallery

 
Suns’ Dragic honored as NBA’s Most Improved Player

By The Associated Press | From Page: B3

Seahawks to open NFL season vs. Packers

By The Associated Press | From Page: B3

 
Oldest living ex-MLB player dies in Cuba at 102

By The Associated Press | From Page: B12

 
.

Business

Wellness programs grow more popular with employers

By The Associated Press | From Page: B5

 
Sales of new US homes plunge 14.5 percent in March

By The Associated Press | From Page: B6

Buffett disapproves of Coca-Cola’s pay plan

By The Associated Press | From Page: B6

 
Amazon snares classic shows in deal with HBO

By The Associated Press | From Page: B6

US stocks edge lower after a six-day rise

By The Associated Press | From Page: B6

 
Facebook 1Q results soar; CFO to step down

By The Associated Press | From Page: B6

Apple increases stock buyback, will split stock

By The Associated Press | From Page: B6, 1 Comment

 
.

Obituaries

Phyllis J. Miller

By Nancy Green | From Page: A4

 
Dondi Martin

By Nancy Green | From Page: A4

.

Comics

Rose is Rose

By Daily Republic Syndicated Content | From Page: A8

 
Garfield

By Daily Republic Syndicated Content | From Page: A8

Pickles

By Daily Republic Syndicated Content | From Page: A8

 
For Better or Worse

By Daily Republic Syndicated Content | From Page: A8

Peanuts

By Daily Republic Syndicated Content | From Page: A8

 
Wizard Of Id

By Daily Republic Syndicated Content | From Page: A8

Dilbert

By Daily Republic Syndicated Content | From Page: A8

 
Baldo

By Daily Republic Syndicated Content | From Page: A8

Blondie

By Daily Republic Syndicated Content | From Page: A8

 
Baby Blues

By Daily Republic Syndicated Content | From Page: A8

Beetle Bailey

By Daily Republic Syndicated Content | From Page: A8

 
Sally Forth

By Daily Republic Syndicated Content | From Page: A8

B.C.

By Daily Republic Syndicated Content | From Page: A8

 
Frank and Ernest

By Daily Republic Syndicated Content | From Page: A8

Get Fuzzy

By Daily Republic Syndicated Content | From Page: A8

 
Zits

By Daily Republic Syndicated Content | From Page: A8

Cryptoquote

By Daily Republic Syndicated Content | From Page: A9

 
Crossword

By Daily Republic Syndicated Content | From Page: A9

Word Sleuth

By Daily Republic Syndicated Content | From Page: A9

 
Bridge

By Daily Republic Syndicated Content | From Page: A9

Sudoku

By Daily Republic Syndicated Content | From Page: A9